We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleXELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.AuthorsCassidy, J.; Clarke, S.; D&a#x00ED;az-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Rittweger, K.; Gilberg, F.; Saltz, L.; Díaz-Rubio, EPublicationBritish Journal of Cancer, 2011, Vol 105, Issue 1, p58ISSN0007-0920Publication typearticleDOI10.1038/bjc.2011.201